All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Circle Pharma, Inc., a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable ...

AstraZeneca's Imfinzi was used before and after surgery in a clinical trial of patients with muscle-invasive bladder cancer — ...

She will report to Teresa Graham, CEO of Roche Pharma, and become a member of the group’s pharma leadership team. “Ashley is a Roche and Genentech veteran, with a 20-year career that spans the ...

SAN FRANCISCO, Sept. 16, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the ...

Find out all you need to know about bispecific antibodies, including how they work and what the current clinical landscape ...

MERGE, a premier storytelling technology company, announced the appointment of Jim Weiss, the visionary founder and chairman ...

Genentech strengthens Roche’s access to innovation ... exactly Roche will be in ten years’ time. In 2012, the current CEO of Roche, Severin Schwan, announced that “more than 60% of [Roche ...

The resignations follow drawn-out negotiations with 23andMe CEO and co-founder Anne Wojcicki, who wants to take the company private. In a Tuesday letter addressed to Wojcicki, the seven directors ...

Chris Gallant has been named the chief executive officer of iconic coconut water and hydration brand, ZICO Rising.